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ABSTRACT The structure and stabilities of the intermediates affect protein folding as well as misfolding and amyloid formation.
By applying Kramer’s theory of barrier crossing and a Morse-function-like energy landscape, we show that intermediates with
mediumstability dramatically increase the rate of amyloid formation; on the other hand, very stable and very unstable intermediates
sharply decrease amyloid formation. Remarkably, extensive molecular dynamics simulations and conformational energy
landscape analysis of Ab25–35 and its N27Q mutant corroborate the mathematical description. Both experimental and current
simulation results indicate that the core of the amyloid structure of Ab25–35 formed from residues 28–35. A single mutation of
N27Q of Ab25–35 makes the Ab25–35 N27Q amyloid-free. Energy landscape calculations show that Ab25–35 has extended
intermediates with medium stability that are prone to form amyloids, whereas the extended intermediates for Ab25–35 N27Q split
into stable and very unstable species that are not disposed to form amyloids. The results explain the contribution of both a-helical
and b-strand intermediates to amyloid formation. The results also indicate that the structure and stability of the intermediates, as
well as of the native folded and the amyloid states can be targeted in drug design. One conceivable approach is to stabilize the
intermediates to deter amyloid formation.
INTRODUCTION
Polypeptide chains can exist in many structural forms, such
as unfolded, natively folded, and misfolded. The native
folded state is the biological functional state. Some proteins
exist in the natively disordered state; however, they trans-
form into the folded state by favorable binding interactions.
Misfolded proteins may form disordered aggregates or or-
dered amyloid ﬁbrils, which are irreversible and toxic (1).
Various intermediate states relate to the transformation be-
tween the native and the amyloid states. The structure and
stabilities of the intermediates can be dependent on or
independent of the folding/unfolding processes (2,3). Some
of the intermediates may assemble to form soluble oligo-
mers, which then lead to amyloid ﬁbrils (4). The prion
disease is a well known example where the normal form of
the prion proteins (PrPC) converts to misfolded PrPSc inter-
mediates, which then form amyloids (5). Amino acid muta-
tions in the protein sequence can affect both folding and
amyloid formation processes (6).
Nature optimizes the protein sequence to escape amyloid
formation (1,4,7). It appears to do that in two ways—by
stabilizing the folded state and destabilizing the amyloid
state. The structure and stabilities of the intermediates, es-
pecially those linked to the amyloid pathway, may also
perturb nature’s selection. The intermediates are usually
more ﬂexible and broadly distributed; it is thus probably
harder to control intermediates than to control the folded and
amyloid states. In addition, it is unclear whether one should
stabilize or destabilize intermediates to modulate amyloid
formation.
The possible effects of the intermediate stability may
account for amyloid-related diseases. Alzheimer’s disease is
a neurodegenerative disorder characterized by the dysfunc-
tion and death of nerve cells responsible for the storage and
processing of information (8). The disease is mainly related
to the altered proteolytic processing of the amyloid precursor
protein, which leads to aggregation of neurotoxic forms of
the amyloid b (Ab)-peptide. One characteristic of Alzheimer’s
disease is the extracellular aggregation of the Ab peptide.
Both the full-length form (Ab1–40 and Ab1–42) and the key
fragment (Ab25–35) form ﬁbrils that are neurotoxic (8–10).
Recently, alternative propositions have been put forward to
explain the pathogenesis of Alzheimer’s disease with the
possibility that a fraction of these Ab peptides stay at the
membrane lipid bilayer after they are generated (11). One
critical mechanism of the cytotoxicity is that the amyloid
proteins/peptides form unregulated ion channels in mem-
branes (12). Ion channels formed by the Alzheimer’s peptide
have been implicated in Alzheimer’s disease pathophysiol-
ogy (13,14). In the pore-formation/ion-channel mechanisms, it
also appears that small oligomers play critical roles.
The sequence of Ab25–35 (GSNKGAIIGLM) has a pos-
itively charged N-terminus and a hydrophobic C-terminus.
The solution structures of the Ab25–35 are a mixture of ran-
dom coil, b-strand, and a-helix (15,16). Hydrogen/deuterium
(H/D)-exchange NMR experiments indicate that the Ab25–35
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amyloid ﬁbrils have a core formed from residues 28–35, with
residues 31 and 32 being the most protected (17). Even
though the H/D-exchange NMR results indicate that N27 is
only marginally protected in the Ab25–35 amyloid ﬁbril, the
Ab25–35 Asn27Gln mutant does not form amyloids (18). It
seems that the difference in amyloid formation for the
Ab25–35 and Asn27Gln mutant does not come from the
perturbation of the amyloid ﬁbril core. To understand why
the N27Q mutation blocks in vitro amyloid formation we
carried out exhaustive simulation studies of both Ab25–35
and Asn27Gln mutant sequences to investigate 1), the
stability of candidate amyloid oligomers and 2), distributions
of free energies for candidate intermediate monomer states
with partial secondary structure formation. Indeed, our
molecular dynamics simulations did not show destabilization
effects of the Asn27Gln of the oligomer clusters of Ab25–35.
In contrast, the relative conformational stabilities of the
Ab25–35monomers are altered in the Asn27Glnmutant, which
may slow the amyloid formation process.
In particular, we ﬁnd a single-mode distribution of the
model free energies for the Ab25–35 peptide in the region of
high extension favorable for amyloid formation, whereas the
mutant peptide has a two-mode ensemble with energies
bracketing those of the Ab25–35 peptide. The mode of the
energy landscape may be used to explain the different be-
havior of amyloid formation. Using Kramer’s theory of bar-
rier crossing and a Morse-function-like energy landscape, we
show that the change of the stability of the intermediates
dramatically increases or decreases the rate of amyloid for-
mation. By considering the barrier-crossing times for a three-
state free energy functional with ﬁxed globally stable disor-
dered and metastable ‘‘amyloid’’ minima but a tunable
intermediate state, we argue that this observation can explain
the blocking of amyloid formation by the mutant sequence.
The key to the argument is that weakly stable intermediates too
easily ﬂip back to the disordered minimum, whereas highly
stable intermediates kinetically trap, so only intermediates with
medium stability can make the transition to the amyloid form.
METHODS
Energy landscape functions and rate of
barrier crossing
To describe the protein aggregation, a double-well potential (Fig. 1) has been
constructed using twoMorse functions, one to describe the well of the tightly
bound amyloid (Uamyloid) and another corresponding to the broad distribution
of native states (Unative). The stability of an intermediate is modeled by a
Gaussian function (Uint). The energy of the amyloid state is adjusted to be
slightly higher than the native state (Fig. 1), whereas the stability of the
intermediates varies with the parameterK. A constant of 95.0 brings the value
of U to the near-conventional 0.
UðxÞ ¼ Uamyloid1Unative  Uint ¼ 1003 ½1 e0:6ðXi4Þ2
1 40003 ½1 e0:015ðXi14Þ2  K3 e0:5ðXi9Þ2  95:
(1)
Wagner and Kiefhaber (19) have applied Kramer’s theory of diffusive
barrier crossing in the high-friction limit to solve the Langevin equation
x
d ¼  D
kBT
@xUðxÞ1 f ðtÞ: (2)
The average time to cross the barrier (the mean ﬁrst-passage time) (19) is
determined by
tðxÞ ¼
Z xs
x
dy
1
D
Z y
xr
dz exp
1
kBT
ðUðyÞ  UðzÞÞ
 
: (3)
In Eqs. 2 and 3, D is the diffusion coefﬁcient, xr is the reﬂecting
boundary, which is set at xr ¼ 20, and xs is the absorbing boundary, which is
set at xs ¼ 4.5. We calculate the mean ﬁrst-passage time of the particle
starting at x ¼ 14 to reach the position of xs ¼ 4.5. The interstrand distance
between the peptide chains in an amyloid b-sheet is around 4.5 A˚, and the
intersheet distance is ;10 A˚. Thus, the xs ¼ 4.5 reﬂects a tightly bound
FIGURE 1 (A) Plot of energy landscape function with different interme-
diate stability (see Eq. 1). (B) The aggregation time, computed using Eq. 3.
In the K-I region, intermediates are not stable and amyloid formation is slow.
In the K-II region, intermediates have medium stability and amyloid
formation is fast. In the K-III region, the intermediates are very stable and
amyloid formation is sharply slower.
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amyloid state and x ¼ 14 refers to the unbound state. The reﬂecting
boundary, xr ¼ 20, may be interpreted as peptides in the well separated state.
Stabilities of the peptide b-sheet oligomers
In all our computations, peptides were not capped. The stabilities of peptide
b-sheet oligomers are simulated with molecular dynamics (MD) simulations
at 330 K. Molecular dynamics simulations were performed in the canonical
ensemble (NVT) with periodic boundary conditions by using the program
Charmm with Charmm22 force ﬁeld. The system consisted of eight peptides
solvated with 3200 water molecules placed in a rectangular box (dimensions
70 3 40 3 40 A˚3). The overall charge of the system is 8. All atoms of the
system were considered explicitly. The time step in the MD simulations is
2 fs, and snapshots from the trajectories were saved every 1 ps. Nonbonded
pairs were updated within 12 A˚ every 25 steps and the nonbonded
interactions were smoothed to zero from 8 to 10 A˚.
Peptide conformational search
The conformational space of the Ab25–35 monomer is systematically
examined by changing the F/C angles of Ab25–35. We used the coarse-
grained F/C state sets developed by Park and Levitt (20), combined with
MD simulated annealing. Thus, all F/C angles of the peptide Ab25–35 and
its N27Q mutant have been exhaustively sampled by all combinations of the
Park-Levitt states, with F/C of (63,63), (132,115), (42,41), and
(44,127). The peptide is ﬁrst minimized by 100 cycles with backbone
constraint. Then 10 additional conformations are sampled near the given
F/C states by MD simulations. The MD sampling has 100 steps with the
temperature increasing from 0 to 800 K. Thus, each Park-Levitt F/C state
has 11 conformations. The total number of conformations sampled is
262,144 for Ab25–35 and similarly 262,144 for its N27Q mutant.
Peptide conformation free energy
The free-energy landscapes are constructed by evaluating the free energies for
individual conformers (21,22). Each conformer is ﬁrst subjected to energy
minimization of 5000 steps with distance-dependent dielectric constant. We
compute thevibrational free-energyGvibrationof theminimizedstructure.Thevibra-
tional free energy has both enthalpic and entropic contributions at 300 K:
Gvibration ¼ Hvibration  TSvibration: (4)
At the minimized state, we compute the conformational energy. The
solvation energies are calculated using the generalized Born method with
molecular volume (GBMV) (23). In the GBMV calculation, the dielectric
constant of water is set to 80, and no distance cutoff is used. The overall
conformational free energy has the following terms:
G ¼ Egas1EGBMV1Esurface1Gvibration; (5)
where Egas is the gas phase potential energy, EGBMV represents the
electrostatic contributions to the solvation energy, Esurface is the cavity and
exposed surface effect on the solvation energy, and Gvibration is solute
vibrational free energy.
RESULTS
Effects of the intermediate stability on the rate of
barrier crossing
A generic model free energy functional with three stable
states is constructed to crudely model amyloid formation.
One minimum is an unfolded monomer, one is a partially
folded intermediate, and one is an attempt to represent an
amyloid. As indicated in Fig. 1 A, the energy landscape has
two stable minima, atU(x¼ 4.44)¼ 5.49 andU(x¼ 13.82)¼
4.48. The barrier is located at U(x ¼ 7.35) ¼ 24.01.
Therefore, the amyloid state at x ¼ 4.44 is a little higher in
energy than the native state at x ¼ 13.82. With K ¼ 15 to
describe the intermediate state, the two energy minima are
U(x¼ 4.44)¼ 5.48 and U(x¼ 13.82)¼ 4.48, and the overall
barrier is atU(x¼ 7.35)¼ 24.01. The intermediate minimum
is at U(x ¼ 9.01) ¼ 4.54. Thus, the intermediate states
described by our functions do not perturb the thermodynamic
stabilities of the native state, transition state, and ﬁnal amy-
loid state. The effects of the intermediate stability on the rate
of barrier crossing are purely kinetic.
Essentially, we can deﬁne three regions based on the
intermediate stability (Fig. 1 B). In the K-I region from K¼ 0
to K ¼ 5, the intermediates are not ‘‘stable,’’ as the potential
function has only shoulder regions corresponding to the
intermediates. However, the shoulder region still increases
the rate of barrier crossing. In the K-II region, the highest rate
of barrier crossing occurs with the medium-stability inter-
mediate states with a well-deﬁned local minimum around
K ¼ 10. Afterwards, in the K-III region, which corresponds
to highly stable intermediate states, the rate of barrier crossing
sharply decreases. Thus, intermediates with medium stability
will increase the rate of crossing, i.e., amyloid formation.
The current generic functions may have no direct physical
correspondence to the kinetics of amyloid formation. For
example, the amyloid minimum in the free-energy function
does not explicitly contain the collective effects associated
with amyloid aggregation. Nevertheless, although not a quan-
titative model, the results described here are suggestive and
can be used to explain how the kinetics of amyloid formation
can be changed by the intermediate free-energy ensembles, as
discussed in the next two sections.
Stability of the oligomeric Ab24–36 octamer,
Ab25–35 octamer, and Ab25–35NQ
mutant octamer
First, we investigate the ability of Ab peptide fragments to
form b-sheet structures in aqueous solution. Experimentally,
amyloid ﬁbrils have been observed for the Ab25–35 se-
quence (8–10,18,24). In the initial studies, conducted together
with other fragments (Ab16–22, Ab16–35, and Ab10–35)
of the Ab peptide (25), we used the Ab24–36 fragment in
our simulations. We considered three antiparallel and four
parallel b-sheet complexes for this Ab24–36 fragment, all in
a double-layered octamer organization (Figs. 2 and 3). We
counted the number of backbone hydrogen bonds and side-
chain contacts between the b-strands in the oligomers to
characterize the stabilities of the models. The cutoff distance
of a hydrogen bond is 2.5 A˚, and the cutoff distance of the Cb
side-chain contact is 7.0 A˚.
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In the antiparallel b-sheet, the hydrophobic interactions
(Fig. 2, residues in red letters) are optimized within the sheet.
All antiparallel b-sheet oligomers are relatively stable. The
stabilities increase with the overlap of the hydrophobic res-
idues. Since the strands are increasingly shifted (translated)
with respect to each other from anti1 to anti2 to anti3, the
number of possible hydrogen bonds should decrease from
anti1 to anti2 to anti3. Yet the anti3 model is themost stable in
terms of hydrogen bonds retained during the 330 K simula-
tions (Fig. 3 A). The core hydrophobic region of the anti3
model holds the octamer together. With respect to the four
parallel b-sheet complexes, three do not survive the high-
temperature simulations and readily dissociate (Fig. 3 B). The
only stable parallel complex is para4, with the two layers
being antiparallel and forming intersheet hydrophobic clus-
ters between –I-G-M- and -M-G-I– (Figs. 2 and 3). Hydro-
phobic interactions, rather than hydrogen bonding, are more
important in stabilizing b-sheet clusters.
Based on the results of the Ab24–36 simulations, we next
simulated the Ab25–35 octamers. The conformations used
are anti2, anti3, and para4 (Fig. 2). In addition, we tested a var-
iation of anti3 with a different intrasheet association (anti4).
The stabilities of the octamer are reported in Fig. 4. Fig. 4 A
plots the trajectory of the hydrogen bonding number, and
Fig. 4 B is the trajectory of side-chain contacts. Generally,
the stabilities for the Ab24–36 and Ab25–35 oligomers are
similar, and both para4 and anti3 octamers have good
stabilities. But the parallel conformation para4 is the most
stable for Ab25–35, and it retains most of the hydrogen
bonds and side-chain contacts (Fig. 4). These results are con-
sistent with experiment. H/D-exchange NMR experiments
indicate that the core of Ab25–35 amyloid ﬁbrils is formed
from residues 28–35, with residues 31 and 32 being the most
protected (17). Structures derived from the NMR experi-
ments (17) are consistent with both anti3 (and anti4) and
para4 oligomers.
The Ab25–35 ﬁbrils have amide band infrared absorp-
tions around 1632 cm1 and 1672 cm1, indicating a pos-
sible antiparallel b-sheet arrangement (18). However, the
x-ray diffraction data do not give a clear pattern of peri-
odicities, indicating a disoriented b-crystalline (26,27). This
could be the result of the ﬂexible ends of either anti3 or the
FIGURE 2 The various antiparallel and parallel arrangements of b-strands in the b-sheet oligomer which are simulated in this work. The oligomers shown
are snapshots from the simulation of Ab24–26. All models consist of two sheets, each with four strands. In some sheets (anti2, anti3, para3), the strands are
shifted with respect to each other within the sheet. In some models (e.g., para2 and para4), the sheets are shifted with respect to each other. The sequence given
is for Ab25–35. Hyrdrophobic regions are in red. (A–C) Antiparallel oligomers. (D) Two parallel oligomers (para1 and para2). (E–F) Two parallel ologimers.
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para4 models disrupting the b-crystalline. Even though, as
shown in Fig. 3, our simulations indicated that the para4 is
the best candidate for the Ab25–35 amyloid, we do not focus
on the absolute stabilities of the parallel or antiparallel olig-
omers. Rather, we focus on the question of why a mutation
that is not in the protected core region can nevertheless lead
to a change in the pattern of amyloid formation.
Experimentally, a single mutation of N27 in Ab25–35 to
Q27 completely blocks the aggregation of Ab25–35. There-
fore, to see if the mutation disrupts the b-sheet oligomer, we
also simulated the oligomeric stabilities of the Ab25–35NQ
octamers in the conformations of anti3 and para4 (Fig. 2) that
are consistent with NMR-deduced aggregation forms. Two
independent simulations (run1 and run2) are performed with
different initial minimization and heating processes for para4
oligomers. The comparison of the stability for parallel
oligomers of the Ab25–35 and its N27Q mutant is reported
in Fig. 5. The black and red lines are trajectories for the the
Ab25–35, and the green and blue lines are for the N27Q
mutant. The comparison of the wild-type with the mutant
oligomer in the anti3 form is represented in Fig. 6, where the
green lines are trajectories for the wild-type and the red lines
for the mutant. Our results indicated that the Ab25–35 N27Q
octamers have stabilities similar to the wild-type Ab25–35
octamers, whether they are in the anti3 or the para4 oligomer
form (Figs. 5 and 6). In the antiparallel orientation, the
Ab25–35 N27Q even has better side-chain contacts during
the 1- to 4-ns simulation run, but the Ab25–35 and its N27Q
mutant have similar stabilities at the end of the simulation
(Fig. 6).
The results are understandable based on the structure of
the octamer, since the N27 is not in the hydrophobic core of
the cluster. Thus, the N27Q mutation does not alter the
oligomer organization. Other factors must exist to cause the
different aggregation behavior of the N27Q mutant. One
possibility is that the N27Q mutation could lead to a very dif-
ferent oligomer structure apart from the parallel/antiparallel
structure examined here. Here we focus on another possibility,
FIGURE 3 The stability of various tested models of Ab24–36 oligomers
in the MD simulations. We count the number of hydrogen bonds in the
snapshots along the trajectory for (A) antiparallel oligomers and (B) parallel
oligomers. FIGURE 4 The stability of tested models of Ab25–35 oligomers in the
MD simulations. On the top, we count the number of hydrogen bonds in the
snapshots along the trajectory; at the bottom are the side-chain contacts.
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indicated already in our study of barrier-crossing kinetics,
relating to the monomeric intermediate stabilities. Even
though the chemical structures of Asn and Gln are similar,
they have signiﬁcant differences in secondary-structure
preference. Asn is known to strongly stabilize b-turn con-
formations (Pturn ¼ 1.56 for Asn and 0.98 for Gln) (28),
whereas Gln shows a preference to form b-strand (Pb¼ 1.10
for Gln and 0.89 for Asn) (28). To characterize the con-
formational behavior, we explored the energy landscapes of
the monomeric Ab25–35 peptide and the Ab25–35 N27Q
mutant.
Energy landscape of the Ab25–35 monomer and
the Ab25–35 N27Q monomer
To characterize the conformational energy landscape of the
peptides, we calculated the conformational free energies for
the 262,144 conformers of the Ab25–35 monomer and for
the same number of conformers of its N27Q mutant. Our
exhaustive combinations of the Park-Levitt F/C states en-
sured the thoroughness of our conformational energy land-
scape. Here, we use the radius of gyration (Rg) to characterize
the extent of the extended state of the peptide conformations.
The larger the radius of gyration, the more extended is the
peptide. Fig. 7 A plots the energy landscape for all con-
formations sampled for the Ab25–35 monomer, and Fig. 7 B
plots that for its N27Q mutant. In Fig. 7, the radii of gyration
for the extended structures are .10 A˚.
For the Ab25–35 monomer, the energies for the lowest 30
conformers range from 557.8 to 560.4 kcal/mol with the radii
of gyration ranging from 5.5 to 9.9 A˚. For the N27Q mutant,
there is still a broad distribution of conformations for the
lowest 30 conformers (radii of gyration range from 5.59 to
10.35 A˚).
FIGURE 5 The stability of the Ab25–35 N27Q mutant oligomer in MD
simulations as compared to the wild-type in para4 oligomer. The black and
red lines are trajectories for the Ab25–35, and the green and blue lines are
for the N27Q mutant.
FIGURE 6 The stability of the Ab25–35 N27Q mutant oligomer in the
MD simulations as compared to the wild-type in anti3 oligomer. Green lines
are trajectories for the wild-type and red lines for the mutant.
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Three NMR structures of the Ab25–35 monomer were
solved in different media (16). In 100 mM sodium dodecyl
sulfate micelles environment, the Ab25–35 assumes a well-
ordered a-helical structure involving residues 28–34 (PDB
code 1qxc, Rg 5.87 A˚). The a-helical structure is still well
folded (PDB code 1qwp, Rg 6.05 A˚) in the 80/20
hexaﬂuoroisopropanol/water mixture. But in the 20/80
hexaﬂuoroisopropanol/water mixture, the a-helical structure
unfolded to form a turn (loop) centered at residues 26 and 27
(PDB code 1qyt, Rg 5.64 A˚). The Ab25–35 peptide is stable
in these solvent media, without aggregation over several
weeks. In aqueous solution, none of the three conformations
are within the lowest 30. The computed energies for the three
known structures are 586 kcal/mol (1qxc), 579 kcal/mol
(1qwp), and 565.4 kcal/mol (1qyt). The energy ranking
correlates well with the trend of decreasing a-helical con-
formation in aqueous solution.
The energy landscapes of the Ab25–35 and its N27Q
mutant explain the difference in the amyloid formation
behavior, as predicted by the kinetic analysis in Fig. 1. The
most favorable intermediates to form amyloids should be the
extended structures with the largest radius of gyration around
10–11 A˚. As can be seen from Fig. 7 A, the energies for these
extended conformations have medium stabilities (K-II). A
single N27Q mutation changes the energy landscape signif-
icantly (Fig. 7 B). The energies for these extended confor-
mations for N27Q mutant fell into two regions, one with
stable intermediates (K-III) and the other with unstable inter-
mediates (K-I).
Therefore, taking Figs. 1 and 7 together, the energy land-
scapes of the Ab25–35 peptide and its N27Q mutant indicate
a difference in their amyloid formation kinetics. For the
Ab25–35 peptide, there is a dense population of intermedi-
ates with extended conformations of medium stability, which
correspond to the K-II region in Fig. 1. The K-II ensemble
has the fastest rate of barrier crossing, and the high speed of
barrier crossing is consistent with the rapid rate of amyloid
formation by Ab25–35. On the other hand, for the N27Q
mutant, the population of the extended intermediates shifted
to the K-I and K-III regions, which have much slower rates of
amyloid formation.
The remarkable correspondence between the monomeric
energy landscape (Figs. 1 and 7) and amyloid formation for
the Ab25–35 peptide and its N27Q mutant argues for
assembling extended conformations in the amyloid forma-
tion process. The propensities of Asn and Gln for b-strand
and b-turn (28) correlate with our energy landscape calcu-
lations. Asn is known to strongly stabilize b-turn confor-
mations (28), which makes the extended structure of only
medium stability in solution and thus easily able to form
amyloids. The propensity to form b-strand is much larger for
Gln than for Asn (28). Therefore, for the N27Q mutant, a
portion of the extended structure is stabilized (Fig. 7). How-
ever, extended intermediates with high stability apparently
decrease the rate of amyloid formation.
Examination of the peptides’ structures in the regions
with a large radius of gyration conﬁrmed the b-strand con-
formations and pointed to a difference in the side-chain
hydrogen-binding pattern. Fig. 8 illustrates three represen-
tative structures of the peptide conformation with the largest
radius of gyration in the three intermediate modes. Fig. 8 A is
the structure of Ab25–35 with the largest Rg value in the K-II
region, Fig. 8 B shows the structure of Ab25–35 N27Q with
the largest Rg value in the K-III region, and Fig. 8 C
illustrates the structure of Ab25–35 N27Q with the largest
Rg value in the K-I region. In Fig. 8, A and B, we observed
hydrogen bonds between the side chains of Ser26 and Lys28.
A new hydrogen-bonding pattern appears in the most stable
intermediate K-I region for the Ab25–35 N27Q. With a
longer side chain, Gln27 can form multiple hydrogen bonds.
Highlighted in the Fig. 8 C is the hydrogen bonding between
the N-terminal group and Gln27. In the K-I region we also see
the hydrogen bonding between the Gln27 with Ser26 (not
shown). These hydrogen bonds do not disturb the b-strand
conformation in the central region and provide additional
FIGURE 7 The energy landscape of monomeric Ab25–35 and Ab25–35
N27Q. (Left) Wild-type sequence. (Right) Mutant sequence. For the N27
(wild-type), the energies of intermediates with extended conformations
(radii of gyration 10–11 A˚) fall within the intermediate range (K-II). For the
mutant, no extended-state intermediates fall within the intermediate stability
range.
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stabilizing force. Of course the side-chain interactions only
represent one factor, other interactions (solvent and entropy)
may also collectively contribute to the difference of the en-
semble of free energies.
DISCUSSION AND CONCLUSIONS
Using a one-dimensional potential barrier model to study the
effects of intermediates on protein folding revealed that
intermediates can accelerate the folding reaction (19,29).
The Wagner and Kiefhaber solution of Eq. 2 provided
an effective way to explore how a change in the potential
function affects the rate of barrier crossing (19). Wagner and
Kiefhaber used the polynomial V(x) ¼ aX6 – bX41 cX21 d
to correlate barrier-crossing and protein-folding intermedi-
ates. By changing the symmetric barrier height, they showed
that intermediates with medium stability can accelerate
protein folding, through a favorable entropy contribution.
Jun and Weaver (29) used a discontinuous potential with a
square barrier to correlate with protein-folding kinetic
intermediates. They also found that the intermediates can
either speed up or slow down folding, depending on their
energy barrier to the ﬁnal folded state.
We extend the approach from protein folding to protein
misfolding in amyloid formation. The extension is natural in
two respects. First, the general mathematical description of
the barrier-crossing property applies equally to protein folding
and to amyloid formation. Our applications with a Morse-
like potential function are closer to the chemical-binding
problem. The Morse function with the form: D*[1 
ea(XiRe)]2 describes a chemical bond with the strength of
D and equilibrium distance of Re. Therefore, our function
may be interpreted as describing an amyloid system with
interstrand distance of 4.5 A˚.
Second, protein folding and misfolding are controlled by
the same energy landscape with the same physicochemical
principles. Protein folding is a diffusion, collision, and co-
alescence process. Amyloid formation, due to its polymeri-
zation nature, is more diffusion- and collision-controlled.
Amyloid formation is very slow compared to protein folding.
The lag time for amyloid formation depends on the speed of
seed formation. The conformational and diffusion entropy
change collectively, constituting a barrier for seed formation.
Even though the size of a stable seed depends on the protein
sequences, it seems that the dimer formation is the most
important step in the amyloid formation (30).
Jang, Hall, and Zhou studied kinetic assembly pathways
of a tetrameric b-sheet complex (31) using molecular dy-
namics simulations. With off-lattice protein models, they
found that the ‘‘folding’’ and equilibrium properties of the
b-sheet complex strongly depend on the interaction param-
eter h. The ‘‘folding’’ yield is high at medium h, but low at
both small and large values of h. In the small value of h,
there are many trapped intermediates that cannot cross the
‘‘folding’’ barrier. Jang and co-workers’ results also reﬂect
the kinetic nature of the amyloid b-sheet formation, similar
to our current analysis of the effects of intermediate stability.
The nature of the ‘‘intermediate’’ described in both pro-
tein folding (19,29) and amyloid formation is not explicitly
deﬁned. In principle, any intermediates on the pathway to
amyloid formation could have kinetic effects on the rate.
For amyloid formation, the intermediates close to the ﬁnal
b-sheet organization should be b-strands. Nevertheless,
a-helical intermediates have been shown to be important for
amyloid formation, especially for the Ab peptide (32). Chiti
et al. showed that the free energy changes of coil to both
a-helices and b-strands affect amyloid formation (33). Fezoui
and Teplow found that the a-helix stabilization is especially
important for the Ab peptide amyloid formation (34). The
contribution of the a-helix stability to the amyloid formation
is often interpreted as the formation of helix-containing olig-
omers, followed by conformational reorganization to form
the extended b-sheet.
Our intermediate stability analysis indicates that the stabi-
lization of an a-helix even before oligomerization can pro-
vide the same rate enhancement effect in amyloid formation.
The stabilization of the a-helix-containing oligomers is not
necessary for amyloid formation. It was found that the
assembly of Ab16–22 into dimers follows multiple routes,
but a-helical intermediates are not obligatory (35). Rather,
FIGURE 8 Representative structures for the intermediates in the three
regions. (A) The structure of Ab25–35 with the largest Rg value in the K-II
region. The side-chain hydrogen bond between Ser26 and Lys28 is
highlighted. (B) The structure of Ab25–35 N27Q with the largest Rg value
in the K-III region; the side-chain hydrogen bond between Ser26 and Lys28 is
highlighted. (C) The structure of Ab25–35 N27Qwith the largest Rg value in
the K-I region. The hydrogen bond between Gly25 and Gln27 is highlighted.
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the a-helix appears to provide a stable intermediate on the
pathway to amyloid, accelerating b-strand formation. Andrec
et al. found that the coil-to-b-hairpin folding is dominated by
pathways that visit metastable helical conformations for the
C-terminal peptide from the B1 domain of protein G (36).
Even for the folding/unfolding of the three-helix bundle
protein A, a stable b-hairpin persists in the unfolded en-
semble and converts to a helix (37). Thus, the stability of the
extended conformation, together with the stability of the
a-helix ‘‘precursor,’’ is likely to be important for peptide olig-
omerization leading to amyloid formation.
How the stability of the extended conformations controls
amyloid formation can also be explained in simple terms of
solubility. Highly soluble intermediates do not easily ag-
gregate, which corresponds to the K-III region in Fig. 1. The
highly insoluble intermediates, which correspond to the K-I
region (Fig. 1), have short population time and can easily ﬂip
back to the native state. For the K-II region, the barrier to the
native state is quite high, but to the amyloid it is still not too
high, thus offering a higher chance for aggregation to pro-
ceed. The ensemble with the intermediate stability of the K-II
region has medium solubility and population time, and is
thus prone to form amyloids.
In conclusion, we have studied barrier crossing and
intermediate stability. Using conformational landscape anal-
ysis and MD simulations, we have investigated the mono-
meric energy landscape and amyloid formation of the native
Ab2535 peptide and its N27Q mutant, which does not form
amyloids experimentally. Our results indicate that Ab2535
intermediates with very low and very high stability will de-
crease the rate of amyloid formation. In contrast, interme-
diates with medium stability will accelerate the rate of
amyloid formation. Remarkably, although the stability of the
N27Q mutant oligomers is similar to that of the wild-type,
the distribution of the N27Q monomer intermediates has a
signiﬁcantly lower population of these medium-stability con-
former species. The signiﬁcance of these results is not only in
explaining the mutational effects of the Ab2535 peptide
and N27Q; rather, these results assist in the comprehension
of the structure and stability of intermediates, as well as the
native folded state and the amyloid state, and can be of use in
our ﬁght against misfolded-protein diseases.
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